| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |